Management of Hyperglycemia in a Patient with Acromegaly Treated with Pasireotide LAR: A Case Study
ABSTRACT: Objective: Pasireotide long-acting release (LAR) demonstrated superior efficacy versus octreotide LAR in a phase III study (C2305) in medically naive patients with acromegaly. Adverse events associated with pasireotide LAR were similar to those with octreotide LAR, except for a higher rate...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-01-01
|
Series: | AACE Clinical Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S237606052030568X |